Literature DB >> 23358879

Clinical and laboratory features of viral hepatitis A in children.

Zuzana Blechová1, Milan Trojánek, Jan Kynčl, Jitka Cástková, Jerry John, Marek Malý, Kristýna Herrmannová, Vilma Marešová.   

Abstract

Recent outbreaks of viral hepatitis A in non-endemic European countries and the potential outbreak risk in susceptible populations has led us to evaluate the clinical characteristics of children hospitalised with hepatitis A. Retrospective study included 118 children (68 boys and 50 girls) with the mean age of 8.5 years hospitalised at Hospital Na Bulovce in Prague from June 2008 to June 2009. The clinical course was symptomatic icteric in 57 (48.3 %) children, symptomatic anicteric in 23 (19.5 %), subclinical in 22 (18.6 %) and asymptomatic inapparent in 16 (13.6 %). The relapse of the disease occurred in three patients. There were no cases of fulminant hepatitis. The most frequent symptoms included jaundice (57 cases), abdominal pain/discomfort (38), vomiting (38), dark urine (37), subfebrility (29) and fever (25). Hepatic injury markers were substantially elevated in icteric patients, but moderate elevations were identified in anicteric and subclinical cases as well. Lower white blood cell and lymphocyte counts were independently associated with symptomatic and more severe clinical course. Active immunisation was provided to 22 patients, and as a post-exposure prophylaxis to 19 of them. The clinical course and laboratory parameters in vaccinated children were not significantly different from non-vaccinated children. The clinical course of hepatitis A was largely self-limiting and benign. Asymptomatic infections are frequent, representing risk for disease spread; however, they are associated with elevations of hepatic injury markers. The inclusion of significant proportion of asymptomatic cases that were identified and investigated only because of active epidemiological surveillance in the outbreak focus represents the particular asset of this study.

Entities:  

Mesh:

Year:  2013        PMID: 23358879     DOI: 10.1007/s00508-012-0316-9

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  27 in total

1.  Hepatitis A: a vaccine at last.

Authors: 
Journal:  Lancet       Date:  1992-05-16       Impact factor: 79.321

Review 2.  Hepatitis A.

Authors:  R S Koff
Journal:  Lancet       Date:  1998-05-30       Impact factor: 79.321

3.  [Etiology of acute viral hepatitis in a pediatric population].

Authors:  M Ramonet; M Ciocca; M Haydée Núñez; A Afazani; O Arusa; N Planes
Journal:  Medicina (B Aires)       Date:  1985       Impact factor: 0.653

4.  Long-term protective effect of post-exposure Havrix administration during viral hepatitis Type A outbreaks.

Authors:  I Kohl; V Nemecek; M Summerová; R Chlíbek; K Nad'ová; O Mináriková
Journal:  Eur J Epidemiol       Date:  2006-12-08       Impact factor: 8.082

5.  Clinical features and molecular characterization of hepatitis A virus outbreak in a child care center in Thailand.

Authors:  Yong Poovorawan; Apiradee Theamboonlers; Voranush Chongsrisawat; Pojchanad Jantaradsamee; Soontaree Chutsirimongkol; Pisit Tangkijvanich
Journal:  J Clin Virol       Date:  2005-01       Impact factor: 3.168

6.  Hepatitis A and E: update on prevention and epidemiology.

Authors:  David FitzSimons; Greet Hendrickx; Alex Vorsters; Pierre Van Damme
Journal:  Vaccine       Date:  2009-11-17       Impact factor: 3.641

Review 7.  Atypical clinical manifestations of hepatitis A.

Authors:  E R Schiff
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

8.  The role of vaccine in controlling hepatitis A epidemics.

Authors:  P D'Argenio; B Adamo; R Cirrincione; G Gallo
Journal:  Vaccine       Date:  2003-06-02       Impact factor: 3.641

Review 9.  Hepatitis A: clinical manifestations and management.

Authors:  Sook-Hyang Jeong; Hyo-Suk Lee
Journal:  Intervirology       Date:  2010-01-05       Impact factor: 1.763

10.  The diverse patterns of hepatitis A epidemiology in the United States-implications for vaccination strategies.

Authors:  B P Bell; C N Shapiro; M J Alter; L A Moyer; F N Judson; K Mottram; M Fleenor; P L Ryder; H S Margolis
Journal:  J Infect Dis       Date:  1998-12       Impact factor: 5.226

View more
  2 in total

1.  Effectiveness of hepatitis A vaccination as post-exposure prophylaxis.

Authors:  Ignasi Parrón; Caritat Planas; Pere Godoy; Sandra Manzanares-Laya; Ana Martínez; Maria Rosa Sala; Sofia Minguell; Nuria Torner; Mireia Jané; Angela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2016-12-07       Impact factor: 3.452

2.  Changes in the epidemiology of hepatitis A outbreaks 13 years after the introduction of a mass vaccination program.

Authors:  Ana Martínez; Sonia Broner; M Rosa Sala; Sandra Manzanares-Laya; Pere Godoy; Caritat Planas; Sofia Minguell; Nuria Torner; Mireia Jané; Angela Domínguez; The Working Group For The Study Of The Immune Status In Health Care; For The Study Of Hepatitis A In Catalonia
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.